SCHEMBL334924

SCHEMBL334924

CC(=O)c1cccc(N(C)C)c1

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.56
ALDH1A1 P00352 5/20 0.56
MAPT P10636 4/20 0.56
HPGD P15428 4/20 0.56
HSD17B10 Q99714 3/20 0.56
TSHR P16473 2/20 0.56
KMT2A Q03164 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
LMNA P02545 2/20 0.53
POLB P06746 1/20 0.53
RAB9A P51151 4/20 0.51
NPC1 O15118 3/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
GFER P55789 1/20 0.51
FYN P06241 1/20 0.50
HTT P42858 1/20 0.49
ALOX15 P16050 1/20 0.48
KCNK3 O14649 1/20 0.47
MAPK1 P28482 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7437201 0.87 ALDH1A1 (0.47) KDM4EALDH1A1MAPTHPGDHSD17B10
SCHEMBL7056764 0.85 HPGD (0.59) KDM4EALDH1A1MAPTHPGDHSD17B10
SCHEMBL12206768 0.84 HSD17B2 (0.50) KDM4EALDH1A1MAPTHPGDHSD17B10
SCHEMBL2894413 0.84 HTT (0.46) KDM4EALDH1A1MAPTHPGDHSD17B10
SCHEMBL24011663 0.84 HTT (0.46) KDM4EALDH1A1MAPTHPGDHSD17B10
SCHEMBL29625195 0.83 KMT2A (0.58) KDM4EALDH1A1MAPTHPGDHSD17B10
SCHEMBL222176 0.83 KMT2A (0.58) KDM4EALDH1A1MAPTHPGDHSD17B10
SCHEMBL10945617 0.82 KMT2A (0.53) KDM4EALDH1A1MAPTHPGDHSD17B10
SCHEMBL16887651 0.82 KMT2A (0.53) KDM4EALDH1A1MAPTHPGDHSD17B10
SCHEMBL2553110 0.82 KMT2A (0.53) KDM4EALDH1A1MAPTHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 177 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4581071-A1 METHOD FOR PRODUCING A MATERIAL FOR A MEMBRANE, MATERIAL, MEMBRANE AND USE OF A MEMBRANE Forschungszentrum Jülich GmbH (DE) 2025-07-09 EP claimed
CN-118184520-A Biphenyl amine compound, preparation method thereof and application thereof in flow battery 中国科学院大连化学物理研究所 2024-06-14 CN claimed
WO-2024046712-A1 METHOD FOR PRODUCING A MATERIAL FOR A MEMBRANE, MATERIAL, MEMBRANE AND USE OF A MEMBRANE Forschungszentrum Jülich GmbH (DE) 2024-03-07 WO claimed
EP-1668409-A4 REVERSIBLE ELECTRO-OPTIC DEVICE EMPLOYING APROTIC MOLTEN SALTS AND METHOD UNIV CALIFORNIA (US) 2008-08-27 EP claimed
EP-1668409-A2 REVERSIBLE ELECTRO-OPTIC DEVICE EMPLOYING APROTIC MOLTEN SALTS AND METHOD The Regents of The University of California (US) 2006-06-14 EP claimed
WO-2004099863-A2 REVERSIBLE ELECTRO-OPTIC DEVICE EMPLOYING APROTIC MOLTEN SALTS AND METHOD THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2004-11-18 WO claimed
EP-4581071-A1 METHOD FOR PRODUCING A MATERIAL FOR A MEMBRANE, MATERIAL, MEMBRANE AND USE OF A MEMBRANE Forschungszentrum Jülich GmbH (DE) 2025-07-09 EP disclosed
CN-120059635-A Double faced adhesive tape and multilayer structure 财团法人工业技术研究院 2025-05-30 CN disclosed
US-20240383868-A1 SMARCA DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. 2024-11-21 US disclosed
CN-118184520-A Biphenyl amine compound, preparation method thereof and application thereof in flow battery 中国科学院大连化学物理研究所 2024-06-14 CN disclosed
WO-2024046712-A1 METHOD FOR PRODUCING A MATERIAL FOR A MEMBRANE, MATERIAL, MEMBRANE AND USE OF A MEMBRANE Forschungszentrum Jülich GmbH (DE) 2024-03-07 WO disclosed
CN-117417867-A Enterobacter cloacae (Enterobacter cloacae) ZJUT16 and application thereof 浙江工业大学 2024-01-19 CN disclosed
CN-117343948-A Recombinant expression plasmid of nitroreductase EcNTR and application thereof 浙江工业大学 2024-01-05 CN disclosed
US-4363503-A FOR PRESSURE SENSITIVE CARBONLESS DUPLICATING AND THERMAL MARKING SYSTEMS STERLING DRUG INC. (US) 1982-12-14 US disclosed
EP-0061128-A1 Pyridine compounds, process for their preparation and systems containing them STERLING DRUG INC. (US) 1982-09-29 EP disclosed
US-4187307-A 4-AMINOPTERIDINES ABBOTT LABORATORIES (US) 1980-02-05 US disclosed
US-4053470-A BACTERICIDES, ANTIBIOTICS PARKE, DAVIS & COMPANY (US) 1977-10-11 US disclosed
US-4017313-A Photosensitive composition containing a leuco dye, a photosensitizer, an aromatic aldehyde and a secondary or tertiary amine and the use thereof in a direct-print process E. I. DU PONT DE NEMOURS AND COMPANY (US) 1977-04-12 US disclosed
US-3954734-A PENICILLIN AND CEPHALOSPORIN TYPE PARKE, DAVIS & COMPANY 1976-05-04 US disclosed
US-3951982-A Trialkylsilyl esters of 6(substituted amino)phenyl-1,-dihydro-2-oxonicotinic acid, methods for their production and conversion to the corresponding acid chlorides PARKE, DAVIS & COMPANY 1976-04-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240383868-A1 SMARCA DEGRADERS AND USES THEREOF SMARCA1, SMARCA2, SMARCC2 KDM4E 223/4885ALDH1A1 2230/4885MAPT 3823/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.